CNY 44.0
(3.58%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 43.05 Million | 144.78 Million | 150.05 Million | 49.76 Million | 42.49 Million | 39.89 Million |
Net Income | 23.12 Million | 119.55 Million | 100.17 Million | 51.55 Million | 39.11 Million | 33.42 Million |
Depreciation & Amortization | 28.77 Million | 31.38 Million | 31.44 Million | 28.27 Million | 27.46 Million | 21.44 Million |
Deferred income taxes | 1.27 Million | 1.06 Million | -841.32 Thousand | -1.47 Million | 63.44 Thousand | -146.05 Thousand |
Stock-based compensation | - | 3.14 Million | 8.63 Million | 13.25 Million | 354.36 Thousand | - |
Change in working capital | -8.43 Million | -1.25 Million | 4.55 Million | -50.25 Million | -24.55 Million | -11.42 Million |
Other non-cash items | 1.16 Million | -9.1 Million | 6.08 Million | 8.41 Million | 50.01 Thousand | -3.54 Million |
Investing Cash Flow | 93.96 Million | -104.12 Million | -53.37 Million | 49.57 Million | -39.02 Million | -88.74 Million |
Investments in PPE | -49.27 Million | -12.52 Million | -18.77 Million | -7.9 Million | -40.42 Million | -57.02 Million |
Acquisitions | - | 1.09 | 13.5 Thousand | 340.79 Thousand | - | - |
Investment purchases | -250 Million | -635 Million | -320 Million | -306 Million | -296 Million | -505 Million |
Sales/Maturities of investments | 390.85 Million | 525.23 Million | 300 Million | 360 Million | 286 Million | 480 Million |
Other Investing Activities | 2.39 Million | 18.15 Million | -14.6 Million | 3.13 Million | 11.39 Million | -6.71 Million |
Financing Cash Flow | -29 Million | -31.28 Million | -35.5 Million | -18.91 Million | -5.25 Million | -34.68 Million |
Debt repayment | -182 Thousand | -60 Million | -102 Thousand | - | -2 Million | - |
Dividends payments | -26.38 Million | -31.04 Million | -35.17 Million | -26.3 Million | -17.34 Million | -34.68 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2.62 Million | 59.76 Million | -229 Thousand | 7.38 Million | 14.12 Million | - |
Accounts receivables | 34.63 Million | 41.93 Million | -39.87 Million | -57.97 Million | -8.41 Million | -9.22 Million |
Accounts payables | -51.6 Million | -38.19 Million | 48.24 Million | 7.4 Million | -20.94 Million | 13.81 Million |
Inventory | 7.25 Million | -6.06 Million | -2.97 Million | 1.79 Million | 4.72 Million | -15.87 Million |
Other working capital | -50.32 Million | 1.06 Million | -841.32 Thousand | -1.47 Million | 63.44 Thousand | 4.44 Million |
Cash at beginning of period | 246.05 Million | 231.59 Million | 171.9 Million | 93.78 Million | 94.56 Million | 174.75 Million |
Cash at end of period | 355.33 Million | 246.05 Million | 231.59 Million | 171.9 Million | 93.78 Million | 94.56 Million |
Capital Expenditure | -49.27 Million | -12.52 Million | -18.77 Million | -7.9 Million | -40.42 Million | -57.02 Million |
Effect of forex changes on cash | 1.26 Million | 5.08 Million | -1.48 Million | -2.3 Million | 1.01 Million | 3.34 Million |
Net cash flow / Change in cash | 109.27 Million | 14.46 Million | 59.69 Million | 78.11 Million | -778.11 Thousand | -80.18 Million |
Free Cash Flow | -6.22 Million | 132.26 Million | 131.27 Million | 41.86 Million | 2.07 Million | -17.13 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 791.91 Thousand | 1.19 Million | 23.12 Million | 2.51 Million | 5.22 Million | 9.9 Million |
Depreciation & Amortization | 10.64 Million | 10.64 Million | 28.77 Million | 28.77 Million | -14.58 Million | 8.13 Million |
Deferred income taxes | - | - | 1.27 Million | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -30.92 Million | - | -8.43 Million | 41.89 Million | -17.07 Million | 17.07 Million |
Other non-cash items | 23.76 Million | -92.77 Thousand | 1.16 Million | -84.85 Million | 37.22 Million | 23.62 Million |
Investing Cash Flow | -45.14 Million | -35.41 Million | 93.96 Million | -6.56 Million | -12.23 Million | 104.66 Million |
Investments in PPE | -45.14 Million | -35.79 Million | -49.27 Million | -6.56 Million | -13.08 Million | -17.12 Million |
Acquisitions | - | - | - | - | - | 0.03 |
Investment purchases | - | - | -250 Million | - | - | -70 Million |
Sales/Maturities of investments | - | 376.69 Thousand | 390.85 Million | 2.39 Million | 851.38 Thousand | 190 Million |
Other Investing Activities | - | 376.69 Thousand | 2.39 Million | -2.39 Million | 0.61 | 1.78 Million |
Financing Cash Flow | -17.58 Million | - | -29 Million | -182 Thousand | -70 Thousand | -28.75 Million |
Debt repayment | - | - | -182 Thousand | - | - | - |
Dividends payments | -17.58 Million | - | -26.38 Million | - | - | -26.38 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -2.62 Million | -182 Thousand | -70 Thousand | -2.37 Million |
Accounts receivables | -24.1 Million | - | 34.63 Million | 34.63 Million | -11.4 Million | 11.4 Million |
Accounts payables | - | - | -51.6 Million | - | - | - |
Inventory | -6.82 Million | - | 7.25 Million | 7.25 Million | -5.66 Million | 5.66 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 341.48 Million | 400.54 Million | 246.05 Million | 373.73 Million | 375.22 Million | 238.97 Million |
Cash at end of period | 304.02 Million | 341.48 Million | 355.33 Million | 355.33 Million | 373.73 Million | 375.22 Million |
Capital Expenditure | -45.14 Million | -35.79 Million | -49.27 Million | -6.56 Million | -13.08 Million | -17.12 Million |
Effect of forex changes on cash | 1.85 Million | 766.54 Thousand | 1.26 Million | 23.73 Thousand | 25.21 Thousand | 1.59 Million |
Net cash flow / Change in cash | -37.46 Million | -59.06 Million | 109.27 Million | -18.4 Million | -1.49 Million | 136.24 Million |
Free Cash Flow | -31.23 Million | -34.69 Million | -6.22 Million | -18.24 Million | -2.29 Million | 41.61 Million |
CMFO
COLL
MICEL
MNARF
002448
CFFS